Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephrogenic Fibrosing Dermopathy”

16 trials

Showing 16 of 16 results

Post-approval studies (Phase 4)UnknownNCT04776187
What this trial is testing

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Who this might be right for
Nephrogenic Fibrosing Dermopathy
The Central Hospital of Lishui City 600
Not applicableStudy completedNCT00600834
What this trial is testing

Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease

Who this might be right for
Renal Insufficiency
Bracco Diagnostics, Inc 172
Not applicableStudy completedNCT01135316
What this trial is testing

Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR

Who this might be right for
Nephrogenic Systemic Fibrosis
Lantheus Medical Imaging 2
Post-approval studies (Phase 4)Study completedNCT00908310
What this trial is testing

Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)

Who this might be right for
Chronic Kidney DiseaseRenal Insufficiency
GE Healthcare 213
Not applicableStudy completedNCT00869479
What this trial is testing

Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis

Who this might be right for
Nephrogenic Systemic Fibrosis
Massachusetts General Hospital 60
Post-approval studies (Phase 4)Study completedNCT00828737
What this trial is testing

Safety of Gadovist in Renally Impaired Patients

Who this might be right for
FibrosisRenal Impairment
Bayer 927
Large-scale testing (Phase 3)UnknownNCT01359345
What this trial is testing

Nephrogenic Systemic Fibrosis With Gadollinum

Who this might be right for
Nephrogenic Systemic FibrosisRenal Failure
Imam Khomeini Hospital 200
Large-scale testing (Phase 3)Study completedNCT00981942
What this trial is testing

Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec

Who this might be right for
Nephrogenic Systemic Fibrosis
University of Aarhus 10
Not applicableStudy completedNCT00773409
What this trial is testing

Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)

Who this might be right for
Renal Insufficiency
Bracco Diagnostics, Inc 405
Not applicableWithdrawnNCT00811863
What this trial is testing

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

Who this might be right for
Nephrogenic Systemic FibrosisRenal Insufficiency
Guerbet
Not applicableStudy completedNCT00744939
What this trial is testing

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Who this might be right for
FibrosisKidney FailureRenal Insufficiency
Bayer 168
Not applicableStudy completedNCT00600951
What this trial is testing

Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease

Who this might be right for
Renal Insufficiency
Bracco Diagnostics, Inc 366
Not applicableStudy completedNCT01014754
What this trial is testing

Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels

Who this might be right for
Nephrogenic Systemic FibrosisNephrogenic Fibrosing Dermopathy
Northwestern University 24
Post-approval studies (Phase 4)Study completedNCT00908596
What this trial is testing

Primovist / Eovist in Renally Impaired Patients

Who this might be right for
Contrast Media
Bayer 357
Post-approval studies (Phase 4)Ended earlyNCT01078987
What this trial is testing

Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)

Who this might be right for
Nephrogenic Fibrosing DermopathyNephrogenic Systemic Fibrosis
Loma Linda University 12
Testing effectiveness (Phase 2)Study completedNCT00677092
What this trial is testing

Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis

Who this might be right for
Nephrogenic Systemic Fibrosis
Massachusetts General Hospital 12

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation